Two Birds of a Feather: AbbVie to Acquire Fellow Price-Gouger Allergan In Multi-Billion Dollar Deal

This week, Big Pharma giant AbbVie announced plans to acquire drug maker Read More

CSRxP Applauds HELP Committee for Taking Up Bipartisan CREATES Act

Encourages Senate Panel to Further Strengthen Drug Price Package with REMEDY Read More

CSRxP: Study Demonstrates Big Pharma Must Be Held Accountable in Part D Reform

Report Finds Significant Catastrophic Liability for Drug Makers Benefits Read More

THEY SAID IT! Senators on Aging Panel Pledge Bipartisan Action To Lower Drug Prices & Hold Big Pharma Accountable

Washington, D.C. – The U.S. Senate Special Committee on Aging held its third Read More

CSRxP: Congress Must Amend USMCA to Protect American Patients

Current Trade Agreement Could Hamper Generic and Biosimilar Competition Read More

CSRxP Encourages HELP Committee To Take Up Bipartisan FAIR Drug Pricing Act

Greater List Price Transparency Will Help Crack Down on Big Pharma’s Read More

CSRxP: Big Pharma Desperate to Distract from Egregious Pricing Practices

Drug Makers Intensify Blame Game While Seeking to Avoid Accountability Read More

CSRxP Urges HELP Committee to Strengthen Drug Pricing Package with Measures to Boost Competition and Transparency

Bipartisan CREATES, FAIR Drug Pricing and REMEDY Acts Will Deliver Relief for Read More

CSRxP: Senators Should Hold Big Pharma Accountable for Patent Abuse, Question Proposal to Loosen Rules

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today Read More

CSRxP Applauds National Governors Association’s Commitment to Lowering Drug Prices

NGA’s “2019 Principles for Federal Action to Address Health Care Costs” Read More

CSRxP Appreciates HELP Leaders’ Bipartisan Commitment to Lowering Drug Prices

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released Read More